https://www.business-standard.com/article/companies/bharat-biotech-to-begin-trials-of-intranasal-vaccine-for-covid-in-feb-mar-121010800340_1.html
The Phase-1 trials will be conducted in Saint Louis University’s Vaccine and Treatment Evaluation Unit
Bharat Biotech to begin trials of intranasal vaccine for Covid in Feb-Mar
Published in Business and Uncategorized
More from BusinessMore posts in Business »
- Unlock Huge Potential with the Next Big Best Cryptos to Buy in 2025
- HSBC Holdings (HSBC) Stock: Q125 Profit Beats Expectations Despite Revenue Drop, Tariff Concerns
- MAGACOIN FINANCE Breaks $7.4M — Whale Executes Largest Early Crypto Buy of 2025
- Bunq Launches Crypto Trading With Kraken in 6 EU Nations
- Novartis (NVS) Stock: Q125 Earnings Beat Boosts Confidence in Oncology and Cardio Drugs
- Crypto news today: Bitcoin tops $95K, stocks rally despite analyst’s ‘blind market’ warning
- SEC delays decision on Franklin Templeton’s spot XRP ETF
- Sonic (S) price prediction: Can native USDC launch on May 6 ignite a breakout?
- Nasdaq files to list 21Shares’ Dogecoin ETF
- Top crypto price predictions today: Chainlink, PepeX
More from UncategorizedMore posts in Uncategorized »
- Unlock Huge Potential with the Next Big Best Cryptos to Buy in 2025
- HSBC Holdings (HSBC) Stock: Q125 Profit Beats Expectations Despite Revenue Drop, Tariff Concerns
- MAGACOIN FINANCE Breaks $7.4M — Whale Executes Largest Early Crypto Buy of 2025
- Bunq Launches Crypto Trading With Kraken in 6 EU Nations
- Novartis (NVS) Stock: Q125 Earnings Beat Boosts Confidence in Oncology and Cardio Drugs
- Crypto news today: Bitcoin tops $95K, stocks rally despite analyst’s ‘blind market’ warning
- SEC delays decision on Franklin Templeton’s spot XRP ETF
- Sonic (S) price prediction: Can native USDC launch on May 6 ignite a breakout?
- Nasdaq files to list 21Shares’ Dogecoin ETF
- Top crypto price predictions today: Chainlink, PepeX